• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Philips appoints Ling Liu as Chief Region Leader of Philips Greater China

    7/3/24 2:00:00 AM ET
    $PHG
    Medical Electronics
    Health Care
    Get the next $PHG alert in real time by email

    July 3, 2024

    Amsterdam, the Netherlands – Royal Philips (NYSE:PHG, AEX: PHIA))), a global leader in health technology, today announced the appointment of Ms Ling Liu as the Chief Region Leader of Philips Greater China, effective immediately. Ms Liu is now a member of Philips' Executive Committee, reporting to Philips CEO Roy Jakobs. She succeeds Andy Ho, who has decided to retire after a long and successful career. Ms Liu and Mr Ho continue to work together to ensure a smooth handover.

    "Ling is a talented, trusted leader and I am delighted that she will join Philips' Executive Committee as the Chief Region Leader of Philips Greater China," said Roy Jakobs, CEO of Royal Philips. "She is a proven executive who brings a wealth of international experience and deep HealthTech expertise in China. I would also like to express my deep gratitude to Andy for his exceptional leadership in delivering on our commitment to supporting China's national health strategy and becoming a trusted partner for professional customers as well as individual consumers. At the same time as driving sustained financial and operational performance over the last nine years."

    Ms Liu joined Philips in 1998 and has held multiple roles across the business, living and working in Greater China, the Netherlands and North America. Most recently, she was Chief Commercial Officer in Greater China, following her role as Head of Finance for Philips in North America. She has a track record of driving execution and boosting performance, developing teams and delivering outstanding value to customers and partners. She is passionate about delivering quality care and contributing to sustainable healthcare in China.

    Ms Liu holds a master of finance and control from Maastricht University, a master's degree in management engineering from Shanghai University, and a bachelor's degree in physics from Zhejiang University.

    2023 marked the 100th anniversary of Philips in China, an achievement that stands as a testament to Philips' commitment and dedication to improving people's lives through meaningful innovation and fostering strong partnerships in China. With sustained growth and being Philips' second largest market, it has been one of the major growth engines for the company. Philips China is focused on supporting China's national health strategy, supplying hospitals with solutions for their clinical and research needs, and empowering consumers to manage their health and well-being. With the aim of better serving the Chinese market, Philips is committed to its ‘In China, For China' strategy, which focuses on local innovation, manufacturing, services and partnership.

    Additional information on Philips' Executive Committee can be found here.



    For further information, please contact:

    Ben Zwirs

    Philips External Relations

    Tel.: +31 6 1521 3446

    E-mail: [email protected]

    Dorin Danu

    Philips Investor Relations

    Tel.: +31 20 59 77055

    E-mail: [email protected]

    About Royal Philips

    Royal Philips (NYSE:PHG, AEX: PHIA))) is a leading health technology company focused on improving people's health and well-being through meaningful innovation. Philips' patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2023 sales of EUR 18.2 billion and employs approximately 69,100 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.

    Forward-looking statements

    This release contains certain forward-looking statements with respect to the financial condition, results of operations and business of Philips and certain of the plans and objectives of Philips with respect to these items. Examples of forward-looking statements include statements made about the strategy, estimates of sales growth, future EBITA, future developments in Philips' organic business and the completion of acquisitions and divestments. By their nature, these statements involve risk and uncertainty because they relate to future events and circumstances and there are many factors that could cause actual results and developments to differ materially from those expressed or implied by these statements.

    Attachments

    • Ling Liu
    • Andy Ho


    Primary Logo

    Get the next $PHG alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $PHG

    DatePrice TargetRatingAnalyst
    2/25/2025Neutral → Outperform
    Exane BNP Paribas
    2/20/2025Neutral → Buy
    UBS
    10/29/2024Underperform → Hold
    Jefferies
    5/13/2024Mkt Perform → Outperform
    Bernstein
    5/7/2024Underperform → Neutral
    Exane BNP Paribas
    4/30/2024Sell → Neutral
    UBS
    4/30/2024Underweight → Neutral
    JP Morgan
    2/7/2024Outperform → Underperform
    Exane BNP Paribas
    More analyst ratings

    $PHG
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Philips upgraded by Exane BNP Paribas

      Exane BNP Paribas upgraded Philips from Neutral to Outperform

      2/25/25 7:12:36 AM ET
      $PHG
      Medical Electronics
      Health Care
    • Philips upgraded by UBS

      UBS upgraded Philips from Neutral to Buy

      2/20/25 7:05:01 AM ET
      $PHG
      Medical Electronics
      Health Care
    • Philips upgraded by Jefferies

      Jefferies upgraded Philips from Underperform to Hold

      10/29/24 6:28:08 AM ET
      $PHG
      Medical Electronics
      Health Care

    $PHG
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Philips shareholders approve all proposals at the AGM 2025

      May 8, 2025 Amsterdam, the Netherlands – Royal Philips (NYSE:PHG, AEX: PHIA)), today announced that its shareholders approved all proposals at the Annual General Meeting of Shareholders (AGM) 2025, including: The re-appointment of Ms Indra Nooyi and Ms Chua Sock Koong as members of the Supervisory Board.The appointment of Mr Bob White as a new member of the Supervisory Board.The re-appointment of Mr Marnix van Ginneken as member of the Board of Management. The discharge of the members of the Board of Management, and of the members of the Supervisory Board.A full overview of the resolutions taken at the AGM 2025 can be found below. Feike Sijbesma, Chairman of Philips' Supervisory Board, sa

      5/8/25 12:16:51 PM ET
      $PHG
      Medical Electronics
      Health Care
    • Philips delivers on Q1 results, with ongoing order intake growth

      May 6, 2025Q1 2025 Group performance Group sales EUR 4.1 billion, reflecting a 2% decline in comparable sales growth mainly due to China; slightly ahead of company outlook due to Personal Health growth and royalty phasingComparable order intake increased 2% despite China declineIncome from operations increased to EUR 154 millionAdjusted EBITA margin declined 80 bps to 8.6% of sales, driven by sales phasingFree cash outflow of EUR 1,091 million included EUR 1,025 million payment for Philips Respironics recall-related medical monitoring and personal injury settlements in USUpdated full year 2025 outlook for Adjusted EBITA margin and free cash flow; sales outlook remains unchanged Roy Jakobs,

      5/6/25 1:00:00 AM ET
      $PHG
      Medical Electronics
      Health Care
    • New Philips Norelco Shaver i9000 Prestige Ultra Introduces the Brand's First "Root-Level" Shave, for Closest Shave Yet

      The World's Most intelligent Shaver from Philips Norelco sets new standards for closeness, comfort and customization. CAMBRIDGE, Mass., May 1, 2025 /PRNewswire/ -- Royal Philips (NYSE:PHG, AEX: PHIA)), a global leader in health technology, is introducing the newest addition to its signature rotary shaving product suite with its most groundbreaking shaver yet. Philips Norelco Shaver i9000 Prestige Ultra, powered by artificial intelligence (AI), is the most intelligent shaver on the market, delivering on maximum comfort, superior precision, and ultimate personalization while providing a seamless user experience and results that last all day.

      5/1/25 9:00:00 AM ET
      $PHG
      Medical Electronics
      Health Care

    $PHG
    Leadership Updates

    Live Leadership Updates

    See more
    • Philips shareholders approve all proposals at the AGM 2025

      May 8, 2025 Amsterdam, the Netherlands – Royal Philips (NYSE:PHG, AEX: PHIA)), today announced that its shareholders approved all proposals at the Annual General Meeting of Shareholders (AGM) 2025, including: The re-appointment of Ms Indra Nooyi and Ms Chua Sock Koong as members of the Supervisory Board.The appointment of Mr Bob White as a new member of the Supervisory Board.The re-appointment of Mr Marnix van Ginneken as member of the Board of Management. The discharge of the members of the Board of Management, and of the members of the Supervisory Board.A full overview of the resolutions taken at the AGM 2025 can be found below. Feike Sijbesma, Chairman of Philips' Supervisory Board, sa

      5/8/25 12:16:51 PM ET
      $PHG
      Medical Electronics
      Health Care
    • Philips proposes new Supervisory Board appointments and reappointments, and Board of Management reappointment

      Mr David Pyott to retire from Philips' Supervisory Board after his third consecutive term.Mr Bob White proposed as new member of the Supervisory Board.Ms Indra Nooyi and Ms Chua Sock Koong proposed for reappointment as members of the Supervisory Board.Mr Marnix van Ginneken proposed for reappointment as member of Philips' Board of Management. February 19, 2025Amsterdam, the Netherlands – Royal Philips (NYSE:PHG, AEX: PHIA)), a global leader in health technology, today announced proposed Supervisory Board appointments and reappointments, and a proposed Board of Management reappointment. Mr David Pyott (British/American, 1953) will retire from Philips' Supervisory Board at the end of the Annu

      2/19/25 1:05:00 AM ET
      $PHG
      Medical Electronics
      Health Care
    • Philips appoints Jie Xue as Chief Business Leader Precision Diagnosis, co-leader of the Diagnosis & Treatment segment, and Özlem Fidanci as Chief of International Region

      January 9, 2025 Amsterdam, the Netherlands – Royal Philips (NYSE:PHG, AEX: PHIA)), a global leader in health technology, today announced the appointment of Jie Xue as Chief Business Leader Precision Diagnosis, and Özlem Fidanci as Chief of International Region, both effective January 1, 2025. Ms. Xue and Ms. Fidanci have joined Philips' Executive Committee and report directly to Roy Jakobs, CEO of Philips.Ms. Xue joins Philips from GE Healthcare to lead the Precision Diagnosis business that was temporarily led by Bert van Meurs, who will continue to lead Philips' Image Guided Therapy business. Ms. Xue and Mr. Van Meurs will be jointly responsible for the Diagnosis & Treatment segment. Ms. F

      1/9/25 4:00:00 AM ET
      $PHG
      Medical Electronics
      Health Care

    $PHG
    SEC Filings

    See more

    $PHG
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form 6-K filed by Koninklijke Philips N.V. NY Registry Shares

      6-K - KONINKLIJKE PHILIPS NV (0000313216) (Filer)

      5/6/25 7:58:01 AM ET
      $PHG
      Medical Electronics
      Health Care
    • SEC Form 6-K filed by Koninklijke Philips N.V. NY Registry Shares

      6-K - KONINKLIJKE PHILIPS NV (0000313216) (Filer)

      3/24/25 8:18:19 AM ET
      $PHG
      Medical Electronics
      Health Care
    • SEC Form 6-K filed by Koninklijke Philips N.V. NY Registry Shares

      6-K - KONINKLIJKE PHILIPS NV (0000313216) (Filer)

      2/21/25 10:15:15 AM ET
      $PHG
      Medical Electronics
      Health Care
    • Amendment: SEC Form SC 13D/A filed by Koninklijke Philips N.V. NY Registry Shares

      SC 13D/A - KONINKLIJKE PHILIPS NV (0000313216) (Subject)

      6/25/24 4:35:57 PM ET
      $PHG
      Medical Electronics
      Health Care
    • SEC Form SC 13D/A filed by Koninklijke Philips N.V. NY Registry Shares (Amendment)

      SC 13D/A - KONINKLIJKE PHILIPS NV (0000313216) (Subject)

      5/16/24 5:52:57 PM ET
      $PHG
      Medical Electronics
      Health Care
    • SEC Form SC 13D filed by Koninklijke Philips N.V. NY Registry Shares

      SC 13D - KONINKLIJKE PHILIPS NV (0000313216) (Subject)

      8/23/23 12:44:28 PM ET
      $PHG
      Medical Electronics
      Health Care

    $PHG
    Financials

    Live finance-specific insights

    See more
    • Philips delivers on Q1 results, with ongoing order intake growth

      May 6, 2025Q1 2025 Group performance Group sales EUR 4.1 billion, reflecting a 2% decline in comparable sales growth mainly due to China; slightly ahead of company outlook due to Personal Health growth and royalty phasingComparable order intake increased 2% despite China declineIncome from operations increased to EUR 154 millionAdjusted EBITA margin declined 80 bps to 8.6% of sales, driven by sales phasingFree cash outflow of EUR 1,091 million included EUR 1,025 million payment for Philips Respironics recall-related medical monitoring and personal injury settlements in USUpdated full year 2025 outlook for Adjusted EBITA margin and free cash flow; sales outlook remains unchanged Roy Jakobs,

      5/6/25 1:00:00 AM ET
      $PHG
      Medical Electronics
      Health Care
    • Philips convenes the Annual General Meeting of Shareholders 2025

      March 24, 2025Amsterdam, the Netherlands – Royal Philips (NYSE:PHG, AEX: PHIA)) today announced it has convened the Annual General Meeting of Shareholders (AGM) 2025 and published the agenda with explanatory notes.As previously announced, the agenda includes: Proposal to appoint Mr Bob White (American, 1962) as a new member of the Supervisory Board, with effect from May 8, 2025.Proposals to re-appoint Ms Indra Nooyi (American, 1955) and Ms Chua Sock Koong (Singaporean, 1957) as members of the Supervisory Board, with effect from May 8, 2025.Proposal to re-appoint Mr Marnix van Ginneken (Dutch, 1973) as a member of the Philips Board of Management, with effect from May 8, 2025.  The agenda fu

      3/24/25 4:00:00 AM ET
      $PHG
      Medical Electronics
      Health Care
    • Philips delivers growth, improved profitability, and strong cash flow in Q4 and 2024; continues solid execution of its three-year plan

      February 19, 2025Full Year and Q4 Group performance highlights Sales of EUR 18.0 billion in 2024, comparable sales growth 1%; EUR 5.0 billion in Q4, comparable sales growth 1%, despite double-digit decline in ChinaComparable order intake increased 1% in 2024; up 2% in Q4, despite double-digit decline in ChinaIncome from operations was EUR 529 million in 2024; EUR 199 million in Q4Adjusted EBITA margin increased 90 basis points to 11.5% of sales in 2024; up 60 basis points to 13.5% in Q4Net cash flow from operating activities was EUR 1,569 million in 2024; EUR 1,459 million in Q4Free cash flow was EUR 906 million in 2024; EUR 1,285 million in Q4Finalized Philips Respironics recall-related me

      2/19/25 1:00:00 AM ET
      $PHG
      Medical Electronics
      Health Care